Plasma adiponectin concentration is strongly associated with VLDL-TG catabolism in postmenopausal women

Nutr Metab Cardiovasc Dis. 2011 Apr;21(4):254-60. doi: 10.1016/j.numecd.2009.10.007. Epub 2010 Feb 13.

Abstract

Background and aims: To investigate associations between plasma adiponectin concentration and very-low density lipoprotein-triglyceride (VLDL-TG) secretion and catabolism in postmenopausal women.

Methods and results: This cross-sectional study included 30 postmenopausal women. Plasma adiponectin concentration was measured by ELISA. Insulin sensitivity was assessed by a 2-h euglycemic-hyperinsulinemic clamp. Fasting plasma glucose (FPG) and 2-hour plasma glucose (2hPG) were measured during an oral glucose tolerance test. The calculation of VLDL-TG fractional catabolic rate (FCR) and VLDL-TG total secretion rate (TSR) were based on the monoexponential decrease of TG-[²H₅] glycerol values obtained following the administration of a ²H₅-glycerol bolus. Plasma adiponectin concentration was negatively associated with VLDL-TG TSR (r=-0.50; p=0.005) and positively associated with VLDL-TG FCR (r=0.54; p<0.002). This latter association remained significant after further adjustments for insulin sensitivity, visceral adipose tissue, HDL-C, FPG and 2hPG concentrations. In a multivariate model including adiponectin, insulin sensitivity and 2hPG, plasma adiponectin level was the strongest correlate of VLDL-TG FCR.

Conclusions: Elevated plasma adiponectin concentration is associated with a favourable VLDL-TG metabolism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood
  • Adiposity
  • Aged
  • Blood Glucose
  • Body Mass Index
  • Cross-Sectional Studies
  • Female
  • Glucose Clamp Technique
  • Glucose Tolerance Test
  • Humans
  • Insulin Resistance
  • Intra-Abdominal Fat
  • Kinetics
  • Lipoproteins, VLDL / metabolism*
  • Middle Aged
  • Postmenopause*
  • Triglycerides / metabolism*

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Blood Glucose
  • Lipoproteins, VLDL
  • Triglycerides